Inspiration Healthcare (IHC) AI Stock Analysis

• Market Cap: £15.47M
• Dividend Yield: N/A
• Average Volume (3M): 31.02K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.26
• Revenue Growth: -16.51%
• EPS Growth: -1655.56%
• Country: UK
• Employees: 224
• Sector: Healthcare
• Sector Strength: 46
• Industry: Medical - Devices
• EPS (TTM): -0.14
• Shares Outstanding: 89,663,370
• 10 Day Avg. Volume: 15,060
• 30 Day Avg. Volume: 31,024
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Inspiration Healthcare's stock score reflects a mix of financial challenges and positive market sentiment. Despite revenue declines and profitability issues, technical indicators and recent corporate events suggest potential recovery and growth. The stock's valuation remains a concern, but confidence from leadership and strategic improvements provide a more optimistic outlook.

Inspiration Healthcare Business Overview & Revenue Model

Company Description

Inspiration Healthcare (IHC) is a global provider of innovative medical technology for critical care, operating primarily in the neonatal intensive care, operating room, and home healthcare sectors. The company's core products and services include advanced respiratory systems, patient monitoring equipment, and medical devices designed to improve patient outcomes and reduce healthcare costs.

How the Company Makes Money

Inspiration Healthcare makes money through the sale of its medical technology products to healthcare providers, hospitals, and clinics worldwide. Key revenue streams include equipment sales, service contracts, and product support services. The company also benefits from partnerships with healthcare institutions and collaborations with research organizations, which can lead to the development of new technologies and expand its market reach.

Inspiration Healthcare Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
37.63M	41.23M	41.05M	36.98M	17.77M
	Gross Profit
17.89M	17.63M	20.25M	17.14M	8.12M
	EBIT
-4.93M	1.49M	4.77M	4.58M	1.57M
	EBITDA
-2.43M	2.76M	6.17M	4.47M	1.76M
	Net Income Common Stockholders
-6.03M	272.00K	4.23M	2.81M	733.00K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
609.00K	2.28M	9.25M	10.65M	4.48M
	Total Assets
49.01M	54.89M	50.11M	43.23M	16.48M
	Total Debt
12.83M	13.08M	7.54M	3.17M	558.00K
	Net Debt
12.42M	10.80M	-1.71M	-7.49M	-3.92M
	Total Liabilities
20.05M	19.42M	14.62M	11.66M	5.93M
	Stockholders Equity
28.97M	35.47M	35.49M	31.58M	10.55M
Cash Flow		Free Cash Flow
380.00K	-11.86M	-436.00K	3.79M	1.09M
	Operating Cash Flow
2.01M	-3.52M	3.54M	4.71M	1.47M
	Investing Cash Flow
-2.69M	-8.34M	-3.97M	-14.06M	-3.38M
	Financing Cash Flow
-1.19M	4.88M	-964.00K	15.53M	3.85M

Inspiration Healthcare Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 17.25
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Positive. The current price of 17.25 is above the 20-day moving average (MA) of 17.01, above the 50-day MA of 17.06, and below the 200-day MA of 17.89, indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 62.09 is Neutral, neither overbought nor oversold. The STOCH value of 39.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IHC.

Inspiration Healthcare Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EKF	68 Neutral	£99.10M	15.94	8.95%	5.61%	-4.59%	165.38%
AMS	66 Neutral	£410.76M	57.82	2.95%	1.26%	40.66%	-55.36%
JDG	63 Neutral	£478.40M	45.93	12.29%	1.36%	-1.84%	9.56%
GNS	62 Neutral	£1.37B	147.63	-0.73%	1.52%	-0.22%	-111.98%
IHC	60 Neutral	£15.47M	―	-30.90%	―	-16.51%	-1655.56%
TRI	58 Neutral	£89.27M	―	-3.67%	2.69%	-4.90%	-21.83%
Sector *	52 Neutral	$5.15B	3.56	-42.52%	2.83%	14.56%	-0.53%

Inspiration Healthcare Corporate Events

Inspiration Healthcare Director Sells Significant Shareholding

Inspiration Healthcare Group plc announced that Neil Campbell, a Non-executive Director, has sold 200,000 ordinary shares in the company. This transaction, conducted in accordance with UK Market Abuse Regulation, leaves Campbell with a 4.7% stake in the company, potentially impacting shareholder dynamics and market perception.

Inspiration Healthcare Director Acquires 100,000 Shares

Inspiration Healthcare has announced that Richard Crispin Morgan Jones, a Non-executive Director, has acquired 100,000 ordinary shares in the company. This transaction signifies a potential vote of confidence in the company’s future prospects and may impact stakeholder perceptions positively, reinforcing market trust in the company’s leadership and strategic direction.

Inspiration Healthcare Reports Strong FY25 Performance and Promising Outlook

Inspiration Healthcare reported a strong performance for the fiscal year ending January 2025, with revenues reaching £38.3 million, driven by a robust second half and strategic cost reductions. The company returned to profitability with positive EBITDA, despite delays in recognizing revenue from a Middle Eastern contract. Key achievements included a $6 million contract with a global humanitarian aid organization and significant cost savings. The company’s ‘Back to Basics’ strategy and new CEO, Raffi Stepanian, are expected to help sustain growth in revenue, profit, and cash generation in FY26.

Mennen Medical Boosts Stake in Inspiration Healthcare

Mennen Medical Ltd., based in Israel, has increased its voting rights in Inspiration Healthcare Group PLC from 8.067% to 9.986%, as of February 7, 2025. This acquisition of voting rights suggests a strengthened position for Mennen Medical within Inspiration Healthcare, potentially influencing company decisions and impacting stakeholders as the voting power increases.

Inspiration Healthcare Announces Board Changes

Inspiration Healthcare Group plc announced the retirement of Bob Beveridge, a Non-Executive Director, effective January 31, 2025. He will be succeeded by Richard Jones, a seasoned professional with extensive experience in the healthcare and life sciences sectors. This transition is expected to leverage Jones’s expertise in capital markets and the US healthcare market, supporting the company’s growth and strategic objectives.

Mennen Medical Increases Stake in Inspiration Healthcare

Inspiration Healthcare Group PLC, a UK-based company, announced a change in voting rights due to Mennen Medical Ltd.’s acquisition of shares. Mennen Medical Ltd., an Israeli company, increased its voting rights in Inspiration Healthcare to 8.067% from 7.51%. This change reflects a significant shift in shareholder influence, potentially impacting future company decisions and shareholder dynamics.

Inspiration Healthcare Appoints New CEO to Drive Growth

Inspiration Healthcare Group plc has appointed Harout Rafi Stepanian as its new Chief Executive Officer, effective January 8, 2025. Stepanian brings extensive experience from previous leadership roles in the healthcare industry, notably as the CEO of Breas Medical. His expertise in respiratory, anaesthesia, and monitoring products, along with a track record of successful international product launches, is expected to help Inspiration Healthcare advance its growth strategy and deliver long-term value to shareholders.